AORT logo

Artivion (AORT)

Profile

Full Name

Artivion, Inc.

Ticker Symbol

AORT

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

February 12, 1993

Indexes

Not included

Website

http://artivion.com

Employees

1600

Key Details

Price

$23.37(-0.68%)

Market cap

$982.66M(Small cap)

Last Dividend

$0.03

TTM Dividend yield

-

Annual revenue

$388.54M(+9.75% YoY)

Annual EPS

-$0.32(+57.33% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$23.37
AORT price is $23.37

30-Day Relative Volume

0.72
AORT 30-day relative volume is 0.72

Price Performance

Price Most recent change

-0.68%
AORT price was down -0.68% on Apr 11, 2025

Price YTD change

-18.26%
AORT price is down -18.26% since January 1st

Price 1-year change

+9.62%
AORT price is up +9.62% year-on-year

Price 3-year change

+11.5%
AORT price is up +11.5% over the past 3 years

Price Range

Price All-time high

$44.82
AORT price is currently -47.86% below its historical high of $44.82

Price 3-year low

$9.64
AORT price is currently +142.43% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$982.66M
AORT market capitalization is $982.66 million

Market cap 3-year change

+16.62%
AORT market capitalization is up +16.62% over the past 3 years

Market cap All-time high

$1.37B
AORT market capitalization is currently -28.25% below its historical high of $1.37 billion

Market cap sector rank

76.58%
AORT market capitalization is higher than 76.58% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.74%
AORT shares outstanding is up +0.74% year-on-year

Shares Outstanding 3-Year Change

+4.59%
AORT shares outstanding is up +4.59% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.80
AORT beta is 0.80

200-day SMA

$26.97
AORT price is currently -13.34% below its 200-day simple moving average

50-day SMA

$26.15
AORT price is currently -10.64% below its 50-day simple moving average

RSI

40.92
AORT 14-day relative strength index is 40.92

Volume

0.72
AORT 30-day relative volume is 0.72

ATR

$1.05
AORT average true range is $1.05

10-day Historical Volatility

56.25%
AORT 10-day historical volatility is 56.25%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.03
AORT last dividend was $0.03 per share, with an ex-dividend date of December 9, 2015

Next Dividend

-
AORT next dividend has not yet been announced

Dividend per share

Dividend per share

-
AORT annual dividend per share value is unknown

Dividend per share Sector Rank

-
AORT annual dividend per share is unknown

Dividend per share 1-Year Change

-
AORT annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
AORT annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
AORT annual dividend yield value is unknown

Dividend yield Sector Rank

-
AORT annual dividend yield is unknown

Other

Payout ratio

-
AORT annual payout ratio value is unknown

Dividends paid

-
AORT annual dividends paid value is unknown

Free cash flow

$11.05M
AORT annual free cash flow is $11.05 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$388.54M
AORT annual revenue is $388.54 million

Revenue Analysts estimate

$423.70M
AORT annual revenue is currently -8.30% lower than the consensus analysts' forecast

Revenue 1-year change

+9.75%
AORT annual revenue is up +9.75% year-on-year

Revenue Sector rank

71.33%
AORT annual revenue is higher than 71.33% of companies in Healthcare sector

EPS

EPS

-$0.32
AORT annual earnings per share is -$0.32

EPS Analysts estimate

$0.58
AORT annual earnings per share is currently -154.94% lower than the consensus analysts' forecast

EPS 1-year change

+57.33%
AORT annual earnings per share is up +57.33% year-on-year

EPS Sector rank

73.91%
AORT annual earnings per share is higher than 73.91% of companies in Healthcare sector

Profit

Gross profit

$248.78M
AORT annual gross profit is $248.78 million

Gross margin

64.03%
AORT annual gross profit margin is 64.03%

Operating profit

$38.87M
AORT annual operating income is $38.87 million

Operating margin

10.01%
AORT annual operating profit margin is 10.01%

Net income

-$13.36M
AORT annual net profit is -$13.36 million

Net margin

-3.44%
AORT annual net profit margin is -3.44%

Expenses

Total expenses

$349.66M
AORT annual total expenses is $349.66 million

Operating expenses

$209.91M
AORT annual total operating expenses is $209.91 million

Cost of goods sold

$139.76M
AORT annual cost of goods sold is $139.76 million

Selling, general & administrative expenses

$181.46M
AORT annual SGA is $181.46 million

Depreciation and amortization

$24.20M
AORT annual depreciation & amortization is $24.20 million

Interest expense

$34.28M
AORT annual interest expense is $34.28 million

Income tax

$5.84M
AORT annual income tax is $5.84 million

EBIT & EBITDA

EBIT

$26.76M
AORT annual earnings before interest & taxes is $26.76 million

EBITDA

$50.97M
AORT annual EBITDA is $50.97 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$789.10M
AORT annual total assets is $789.10 million

Non current assets

$499.02M
AORT annual long term assets is $499.02 million

Current assets

$290.08M
AORT annual total current assets is $290.08 million

Cash and cash equivalents

$53.46M
AORT annual cash & cash equivalents is $53.46 million

Accounts receivable

$79.46M
AORT annual accounts receivable is $79.46 million

Inventory

$79.77M
AORT annual inventory is $79.77 million

Liabilities

Total liabilities

$512.90M
AORT annual total liabilities is $512.90 million

Long term liabilities

$446.08M
AORT annual total long term liabilities is $446.08 million

Current liabilities

$66.82M
AORT annual total current liabilities is $66.82 million

Accounts payable

$17.97M
AORT annual accounts payable is $17.97 million

Debt

Total debt

$362.26M
AORT annual total debt is $362.26 million

Total debt 1-year change

+1.09%
AORT annual total debt is up +1.09% year-on-year

Long term debt

$356.97M
AORT annual long term debt is $356.97 million

Short term debt

$5.29M
AORT annual short term debt is $5.29 million

Equity & Capital

Shareholders equity

$276.20M
AORT annual stockholders equity is $276.20 million

Book value

$276.20M
AORT annual book value is $276.20 million

Retained earnings

-$61.27M
AORT annual retained earnings is -$61.27 million

Working capital

$223.26M
AORT annual working capital is $223.26 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$22.24M
AORT annual cash flow from operations is $22.24 million

Cash from operations 1-year change

+18.12%
AORT annual cash flow from operations is up +18.12% year-on-year

Cash from investing

-$28.19M
AORT annual cash flow from investing activities is -$28.19 million

Cash from investing 1-year change

-5515.14%
AORT annual cash flow from investing activities is down -5515.14% year-on-year

Cash from financing

$2.20M
AORT annual cash flow from financing activities is $2.20 million

Cash from financing 1-year change

+154.68%
AORT annual cash flow from financing activities is up +154.68% year-on-year

CAPEX

CAPEX

$11.19M
AORT annual capital expenditures is $11.19 million

CAPEX 1-year change

+50.58%
AORT annual capital expenditures is up +50.58% year-on-year

Free Cash Flow

Free cash flow

$11.05M
AORT annual free cash flow is $11.05 million

Free cash flow 1-year change

-3.05%
AORT annual free cash flow is down -3.05% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

64.03%
AORT annual gross profit margin is 64.03%

Operating margin

10.01%
AORT annual operating profit margin is 10.01%

Net margin

-3.44%
AORT annual net profit margin is -3.44%

ROA & ROE

ROA

-1.69%
AORT annual return on assets is -1.69%

ROE

-4.79%
AORT annual return on equity is -4.79%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
AORT price to earnings ratio value is unknown

PE ratio Sector rank

-
AORT price to earnings ratio is unknown

PB Ratio

PB ratio

3.56
AORT price to book ratio is 3.56

PB ratio Sector rank

76.56%
AORT price to book ratio is higher than 76.56% of companies in Healthcare sector

PS Ratio

PS ratio

2.53
AORT price to sales ratio is 2.53

PS ratio Sector rank

47.95%
AORT price to sales ratio is higher than 47.95% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.29B
AORT enterprise value is $1.29 billion

Enterprise value Sector rank

77.66%
AORT enterprise value is higher than 77.66% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

25.34
AORT EV/EBITDA is 25.34

EV/EBITDA Sector rank

93.84%
AORT EV/EBITDA is higher than 93.84% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.34
AORT annual current ratio is 4.34

Quick ratio

3.15
AORT annual quick ratio is 3.15

Leverage

Debt to equity

1.14
AORT annual debt to equity ratio is 1.14

Interest coverage ratio

0.78
AORT annual interest coverage ratio is 0.78

Risk & Stability

Piotroski F-Score

3
AORT piotroski f-score is 3

Altman Z-Score

1.98
AORT altman z-score is 1.98

Analyst ratings

Recent major analysts updates

Feb 25, 25 Stifel
Buy
Feb 25, 25 Needham
Buy
Feb 25, 25 Citizens Capital Markets
Market Outperform
Jan 28, 25 Needham
Buy
Dec 10, 24 JMP Securities
Market Outperform
Dec 9, 24 Needham
Buy
Nov 8, 24 Oppenheimer
Outperform
Oct 23, 24 JMP Securities
Market Outperform
Sep 27, 24 Needham
Buy
Sep 13, 24 Stifel
Buy

Institutional Ownership

Similar stocks

TXG logo
10x Genomics (TXG)
VRDN logo
Viridian Therapeutics (VRDN)
HSTM logo
HealthStream (HSTM)
BGM (BGM)
SNDX logo
Syndax Pharmaceuticals (SNDX)
MDXG logo
MiMedx (MDXG)
INMD logo
InMode (INMD)
OPK logo
OPKO Health (OPK)
AUPH logo
Aurinia Pharmaceuticals (AUPH)
  • What is the ticker symbol for Artivion?
  • Does Artivion pay dividends?
  • What sector is Artivion in?
  • What industry is Artivion in?
  • What country is Artivion based in?
  • When did Artivion go public?
  • Is Artivion in the S&P 500?
  • Is Artivion in the NASDAQ 100?
  • Is Artivion in the Dow Jones?
  • When was Artivion's last earnings report?
  • When does Artivion report earnings?
  • Should I buy Artivion stock now?

What is the ticker symbol for Artivion?

The ticker symbol for Artivion is NYSE:AORT

Does Artivion pay dividends?

No, Artivion does not pay dividends

What sector is Artivion in?

Artivion is in the Healthcare sector

What industry is Artivion in?

Artivion is in the Medical Devices industry

What country is Artivion based in?

Artivion is headquartered in United States

When did Artivion go public?

Artivion's initial public offering (IPO) was on February 12, 1993

Is Artivion in the S&P 500?

No, Artivion is not included in the S&P 500 index

Is Artivion in the NASDAQ 100?

No, Artivion is not included in the NASDAQ 100 index

Is Artivion in the Dow Jones?

No, Artivion is not included in the Dow Jones index

When was Artivion's last earnings report?

Artivion's most recent earnings report was on Feb 24, 2025

When does Artivion report earnings?

The next expected earnings date for Artivion is May 6, 2025

Should I buy Artivion stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page